BackChina SXT Pharmaceuticals Overview
China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals Return on Equity

China SXT Pharmaceuticals (SXTC) has a ROE of -24.82%, below the Consumer Discretionary sector average of 22.55%.

Get informed when a big investor buys or sells

+ Follow

ROE

-24.82%

Return on Equity

-24.82%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

China SXT Pharmaceuticals (SXTC) FAQ

As of the most recent data, SXTC shows a ROE of -24.82%. That is below the Consumer Discretionary sector average of 22.55%. Scroll down for historical charts and peer comparison views.

The Consumer Discretionary sector average ROE is about 22.55%. China SXT Pharmaceuticals is at -24.82%, which is lower that average. That is roughly 210.1% below the sector mean. Use the comparison chart on this page to see how SXTC stacks up against individual peers as well.

Check the historical chart to see whether SXTC's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare China SXT Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has China SXT Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -24.82%) with ownership activity and broader fundamentals.

The Consumer Discretionary average ROE is about 22.55%, while SXTC is at -24.82%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.